Abstract
New imaging technology allows us to study neurologic disorders that have had no previous structural basis. There have been recent reports on the involvement of nociceptive pathways in daily headache. A systematic review was performed using key words “chronic daily headache” and “imaging.” This paper reviews the literature on imaging studies performed on daily headache with emphasis on the new imaging technology.
Similar content being viewed by others
References and Recommended Reading
Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1–96.
Silberstein SD, Lipton R, Solomon S, Mathew N: Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994, 34:1–7.
Sjaastad O, Spierings EL: Hemincraia continua: another headache absolutely responsive to indomethicin. Cephalalgia 1984, 4:65–70.
Diaz-Mitoma F, Vanast WJ, Tyrrell DL: Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987, 1:411–415.
Mathew NT, Stubits E, Nigam M: Transformation of migraine into daily headache: analysis of factors. Headache 1982, 22:66–68.
Wang HZ, Simonson TM, Greco WR, Yuh WTC: Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms. Acad Radiol 2001, 8:405–408.
Weingarten S, Kleinman M, Elperin L, Larson EB: The effectiveness of cerebral imaging in the diagnosis of chronic headache. Arch Intern Med 1992, 152:2457–2462.
Raskin NH, Hosobuchi Y, Lamb S: Headache may arise from perturbation of brain. Headache 1987, 27:416–420.
Weiller C, May A, Limmroth V, et al.: Brainstem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658–660.
Knight YE, Goadsby PJ: The periaqueductal gray matter modulates trigeminovascular input: a role in migraine. Neuroscience 2001, 106:793–800.
Haas DC, Kent PF, Friedman DI: Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993, 33:452–455.
Goadsby PJ: Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 2002, 22:107–111. Illustrative case of brainstem lesion and chronic headache in the region of the periaqueductal gray.
Mathew NT, Kailasam J Meadors L: Cavernous angiomas in the “brain stem generator” areas but not in other brain sites causing chronic migraine in subjects with familial cavernous angiomas. Headache 2002, 42:447–448.
Welch KMA, Cao Y, Aurora SK, et al.: MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998, 51:1465–1469.
Cao Y, Aurora SK, Vikingstad EM, et al.: Functional MRI of the red nucleus and occipital cortex during visual stimulation of subjects with migraine. Neurology 2002, 59:72–78. This study confirmed activation in structures such as the red nucleus and substantia nigra during provoked migraine.
Iadarola MJ, Berman KF, Zeffiro TA, et al.: Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain 1998, 121:931–947.
Morris CM, Candy JM, Omar S, et al.: Transferrin receptors in the parkinsonian midbrain. Neuropathol Appl Neurobiol 1994, 20:468–472.
Gelman N, Gorell JM, Barker PB, et al.: MR Imaging of human brain at 3.0 T: preliminary report of transverse relaxation rates and relation to estimated iron content. Radiology 1999, 210:759–767.
Welch KMA, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness. Headache 2001, 41:629–637. This study demonstrated dysfunction of the periaqueductal gray (PAG) in migraine. The increase in dysfunction of PAG may be responsible for the chronicity of migraine.
Kruit MC, van Buchem MA, Overbosch J, et al.: Iron deposits in migraine: red nucleus and putamen involved? A population based case-control MR imaging study, the camera-project. Cephalalgia 2002, 22:571. This study added to the evidence of dysfunctional brainstem structures in migraine.
Aurora SK, Nagesh V, Norris L, Welch KMA: Functional imaging of subcortical nociceptive structures in response to treatment of chronic daily headache. Cephalalgia 2002, 22:570. This is a study showing dynamic changes in the red nucleus and substatia nigra in migraine.
Smith GS, Savery D, Marden C, et al.: Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal gray in the rat. 1: J Comp Neurol 1994, 350:23–40.
Criswell HE: Analgesia and hyperactivity following morphine microinjection into mouse brain. Pharmacol Biochem Behav 1976, 4:23–26.
Christie MJ, Williams JT, Osborne PB, Bellchambers CE: Where is the locus in opioid withdrawal? Trends Pharmacol Sci 1997, 18:134–140.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aurora, S.K. Imaging chronic daily headache. Current Science Inc 7, 209–211 (2003). https://doi.org/10.1007/s11916-003-0074-5
Issue Date:
DOI: https://doi.org/10.1007/s11916-003-0074-5